Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 119,379 | 141,619 | 160,733 | 198,222 | 306,256 |
| Marketable Securities | 45,035 | 65,041 | 89,533 | 89,532 | N/A |
| Inventories | 6 | N/A | N/A | N/A | N/A |
| Other current assets | 3,930 | 4,769 | 2,843 | 3,085 | 1,311 |
| TOTAL | $168,350 | $211,429 | $253,109 | $290,839 | $307,567 |
| Non-Current Assets | |||||
| PPE Net | 7,681 | 7,583 | 6,673 | 6,699 | 6,611 |
| Intangibles | 3,124 | 2,948 | 981 | 5,627 | 5,785 |
| Other Non-Current Assets | 1,038 | 1,037 | 949 | 749 | 749 |
| TOTAL | $11,843 | $11,568 | $8,603 | $13,075 | $13,145 |
| Total Assets | $180,193 | $222,997 | $261,712 | $303,914 | $320,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,115 | 1,952 | 1,790 | 1,626 | 1,454 |
| Accounts payable and accrued liabilities | 8,267 | 8,274 | 10,394 | 6,722 | 5,728 |
| Accrued Expenses | 25,926 | 19,404 | 14,751 | 14,819 | 13,157 |
| Other current liabilities | 698 | 433 | 136 | 136 | 136 |
| TOTAL | $48,866 | $39,858 | $34,358 | $29,201 | $25,372 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,100 | 9,625 | 10,150 | 10,678 | 11,215 |
| Deferred Revenues | 3,764 | 3,305 | 2,763 | 1,194 | 1,263 |
| Other Non-Current Liabilities | 6,870 | 6,375 | 3,421 | 2,532 | 60,493 |
| TOTAL | $18,476 | $18,476 | $15,865 | $17,448 | $75,199 |
| Total Liabilities | $67,342 | $58,334 | $50,223 | $46,649 | $100,571 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 183,818 | 166,658 | 166,205 | 165,729 | 158,930 |
| Common Shares | 167 | 167 | 166 | 165 | 158 |
| Retained earnings | -777,835 | -717,382 | -664,169 | -612,857 | -556,963 |
| Other shareholders' equity | 20 | 20 | -1 | -15 | 0 |
| TOTAL | $112,851 | $164,663 | $211,489 | $257,265 | $220,141 |
| Total Liabilities And Equity | $180,193 | $222,997 | $261,712 | $303,914 | $320,712 |